Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Spruce Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Spruce Biosciences Inc
Rating: 1.04425
Author: Trendlyne DVM scores

about

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aim...

59.00 1.45 (2.52%)

75.42% Fall from 52W High

29,250

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Spruce Biosciences Inc is on 21 May 2026 for the purpose of Spruce Biosciences Inc Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

6.5 / 100

Technically Neutral

35.3 / 100

198

1Yr Price target upside is 236%

4 analysts

Spruce Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aim...

75.42% Fall from 52W High

SWOT Analysis

Spruce Biosciences Inc Live Price Chart